Ejaculatory Abstinence in IUI Cycles
- Conditions
- InfertilitySpermatozoaReproductive Disorder
- Interventions
- Procedure: INTRAUTERINE INSEMINATION
- Registration Number
- NCT04361292
- Lead Sponsor
- Pamukkale University
- Brief Summary
Intrauterine insemination (IUI) combined with ovarian stimulation, has been an extensively used procedure for the treatment of patients with unexplained infertility. The aim of this study was to report the effect of ejaculatory abstinence on sperm DNA fragmentation and pregnancy rates in IUI cycles, as well as the correlation between the two.
- Detailed Description
Intrauterine insemination (IUI) combined with ovarian stimulation, has been an extensively used procedure for the treatment of patients with unexplained infertility. The fact that IUI is less expensive, less invasive, and easier to perform than other assisted reproductive techniques makes it the first-line treatment option in infertility treatments. Several studies have been published over the past few years examining the relationship between sperm DNA fragmentation and IUI outcome. The optimal period for ejaculatory abstinence before the semen sample is a controversial issue in the literature. There are only two retrospective studies examining the relationship between the ejaculatory abstinence period and pregnancy rates after IUI.
Several studies suggested performing IUI with sperm samples obtained in a shorter abstinence period than recommended by WHO. However, there isn't enough research on this issue in the literature. Moreover, there is no specific prospective clinical research examining the relationship of ejaculatory abstinence period and sperm DNA fragmentation in IUI cycles. The aim of this study was to report the effect of ejaculatory abstinence on sperm DNA fragmentation and pregnancy rates in IUI cycles, as well as the correlation between the two
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
- Infertility for more than 12 months
- Diagnosed as unexplained infertility
- Female age between 20 and 40 years
- Regular menstrual cycles
- Mid-luteal progesterone levels of >3 ng/ml
- Basal FSH <12 mIU/ml, AMH >1ng/ml
- Body mass index (BMI) 19-35 kg/m2
- No pelvic pathology documented by transvaginal ultrasound and bilateral tubal patency diagnosed by hysterosalpingography
- Normal semen parameters according to WHO criteria
- Any endocrine and pelvic pathology
- PCOS (polycystic ovarian syndrome)
- Known endometriosis history
- Prior pelvic surgery
- Persistent ovarian cysts.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group B: three days abstinence period INTRAUTERINE INSEMINATION Patients allocated into group B had an ejaculatory abstinence period of three days Group A: one day abstinence period INTRAUTERINE INSEMINATION Patients allocated into group A had an ejaculatory abstinence period of one day
- Primary Outcome Measures
Name Time Method pregnancy rate The pregnancy test was done 14 days after intrauterine insemination. If the test was positive, transvaginal ultrasonography was performed at 6-7 weeks of gestation. The presence of one or more gestational sacs on transvaginal ultrasonography was described as clinical pregnancy.
- Secondary Outcome Measures
Name Time Method Sperm DNA fragmentation percentage On the day of IUI, semen samples were obtained and the sperm DNA fragmentation was measured by the TUNEL method in the inseminated sperm. Sperm DNA fragmentation rate assessed by TUNEL assay.
Trial Locations
- Locations (1)
Pamukkale University Faculty of Medicine, Obstetrics and Gynecology Department, Infertility Center
🇹🇷Denizli, Turkey